Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 125

1.

Green tea polyphenol extract attenuates inflammation in interleukin-2-deficient mice, a model of autoimmunity.

Varilek GW, Yang F, Lee EY, deVilliers WJ, Zhong J, Oz HS, Westberry KF, McClain CJ.

J Nutr. 2001 Jul;131(7):2034-9.

2.

Green tea polyphenols block endotoxin-induced tumor necrosis factor-production and lethality in a murine model.

Yang F, de Villiers WJ, McClain CJ, Varilek GW.

J Nutr. 1998 Dec;128(12):2334-40.

3.

Anti-TNF-alpha antibody normalizes serum leptin in IL-2 deficient mice.

Gaetke LM, Oz HS, Frederich RC, McClain CJ.

J Am Coll Nutr. 2003 Oct;22(5):415-20.

PMID:
14559934
4.

Effects of green tea polyphenols on murine transplant-reactive T cell immunity.

Bayer J, Gomer A, Demir Y, Amano H, Kish DD, Fairchild R, Heeger PS.

Clin Immunol. 2004 Jan;110(1):100-8.

PMID:
14962801
5.

Modulation of colonic inflammation in Mdr1a(-/-) mice by green tea polyphenols and their effects on the colon transcriptome and proteome.

Barnett MP, Cooney JM, Dommels YE, Nones K, Brewster DT, Park Z, Butts CA, McNabb WC, Laing WA, Roy NC.

J Nutr Biochem. 2013 Oct;24(10):1678-90. doi: 10.1016/j.jnutbio.2013.02.007.

PMID:
23643524
6.

Distinct inflammatory mechanisms mediate early versus late colitis in mice.

Spencer DM, Veldman GM, Banerjee S, Willis J, Levine AD.

Gastroenterology. 2002 Jan;122(1):94-105.

PMID:
11781285
7.
8.

The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model.

Ghia JE, Blennerhassett P, Kumar-Ondiveeran H, Verdu EF, Collins SM.

Gastroenterology. 2006 Oct;131(4):1122-30.

PMID:
17030182
9.

Neutralization of interleukin-18 reduces severity in murine colitis and intestinal IFN-gamma and TNF-alpha production.

Siegmund B, Fantuzzi G, Rieder F, Gamboni-Robertson F, Lehr HA, Hartmann G, Dinarello CA, Endres S, Eigler A.

Am J Physiol Regul Integr Comp Physiol. 2001 Oct;281(4):R1264-73.

10.

Antioxidants as novel therapy in a murine model of colitis.

Oz HS, Chen TS, McClain CJ, de Villiers WJ.

J Nutr Biochem. 2005 May;16(5):297-304.

PMID:
15866230
12.

Novel approaches to chemoprevention of skin cancer.

Bickers DR, Athar M.

J Dermatol. 2000 Nov;27(11):691-5. Review.

PMID:
11138532
14.

A novel sphingosine 1-phosphate receptor agonist, 2-amino-2-propanediol hydrochloride (KRP-203), regulates chronic colitis in interleukin-10 gene-deficient mice.

Song J, Matsuda C, Kai Y, Nishida T, Nakajima K, Mizushima T, Kinoshita M, Yasue T, Sawa Y, Ito T.

J Pharmacol Exp Ther. 2008 Jan;324(1):276-83.

15.
16.
17.

Immunomodulatory therapeutic effect of glatiramer acetate on several murine models of inflammatory bowel disease.

Aharoni R, Kayhan B, Brenner O, Domev H, Labunskay G, Arnon R.

J Pharmacol Exp Ther. 2006 Jul;318(1):68-78.

18.

Activation of A2A adenosine receptor attenuates intestinal inflammation in animal models of inflammatory bowel disease.

Odashima M, Bamias G, Rivera-Nieves J, Linden J, Nast CC, Moskaluk CA, Marini M, Sugawara K, Kozaiwa K, Otaka M, Watanabe S, Cominelli F.

Gastroenterology. 2005 Jul;129(1):26-33.

PMID:
16012931
19.

Rapid development of colitis in NSAID-treated IL-10-deficient mice.

Berg DJ, Zhang J, Weinstock JV, Ismail HF, Earle KA, Alila H, Pamukcu R, Moore S, Lynch RG.

Gastroenterology. 2002 Nov;123(5):1527-42.

PMID:
12404228
20.

The opioid antagonist naltrexone improves murine inflammatory bowel disease.

Matters GL, Harms JF, McGovern C, Fitzpatrick L, Parikh A, Nilo N, Smith JP.

J Immunotoxicol. 2008 Apr;5(2):179-87. doi: 10.1080/15476910802131469.

PMID:
18569389
Items per page

Supplemental Content

Support Center